Adjunctive benefits of systemic etoricoxib in non-surgical treatment of aggressive periodontitis: Short-term evaluation

Journal of Periodontology

Volumn 79, Issue 9, 2008, Pages 1719-1725

  Azoubel, Maria Cecília F ^a   Sarmento, Viviane A ^b   Cangussú, Vima ^b   Azoubel, Eduardo ^c   Bittencourt, Sandro ^c   Cunha, Fernando Q ^d   Ribeiro, Ronaldo A ^a   Brito, Gerly Anne C ^a,e  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e NONE   (Brazil)

Author keywords

Anti inflammatory agents; Clinical trial; Dental scaling; Etoricoxib; Periodontitis; Root planing

Indexed keywords

ETORICOXIB; PLACEBO; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRIDINE DERIVATIVE; SULFONE;

ADOLESCENT; ADULT; ARTICLE; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GINGIVA BLEEDING; GINGIVITIS; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; OSTEOLYSIS; PATHOLOGY; PERIODONTAL DISEASE; PERIODONTITIS; PILOT STUDY; PREVENTIVE DENTISTRY; RANDOMIZED CONTROLLED TRIAL; TOOTH CERVIX;

ADOLESCENT; ADULT; ALVEOLAR BONE LOSS; COMBINED MODALITY THERAPY; CYCLOOXYGENASE INHIBITORS; DENTAL SCALING; DINOPROSTONE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GINGIVAL CREVICULAR FLUID; GINGIVAL HEMORRHAGE; HUMANS; MALE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PERIODONTITIS; PILOT PROJECTS; PLACEBOS; PYRIDINES; ROOT PLANING; SULFONES; TOOTH CERVIX;

EID: 51249086890     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.080019     Document Type: Article

References (39)

1. Sjödin B, Matsson L. Marginal bone loss in the primary dentition. A survey of 7-to-9-year-old children in Sweden. J Clin Periodontol 1994;21:313-319.
2. Tonetti MS, Mombelli A. Early-onset periodontitis. Ann Periodontol 1999;4:39-53.
3. Kamma JJ, Baehni PC. Five-year maintenance followup of early-onset periodontitis patients. J Clin Periodontol 2003;30:562-572.
4. D'Aiuto F, Ready D, Parkar M, Tonetti MS. Relative contribution of patient-, tooth-, and site-associated variability on the clinical outcomes of subgingival debridement. I. Probing depths. J Periodontol 2005;76: 398-405.
5. Guerrero A, Griffiths GS, Nibali L, et al. Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: A randomized placebo-controlled clinical trial. J Clin Periodontol 2005;32:1096-1107.
6. Moreira RM, Feres-Filho EJ. Comparison between full-mouth scaling and root planing and quadrant-wise basic therapy of aggressive periodontitis: 6-month clinical results. J Periodontol 2007;78:1683-1688.
7. Ciancio SG. Farmacoterapia. In: Cohen W, Mealey BL, eds. Periodontal Medicine, vol. 1 (in Portuguese). São Paulo: Santos; 2002:243-272.
8. Kaner D, Bernimoulin JP, Hopfenmüller W, Kleber BM, Friedmann A. Controlled-delivery Chlorhexidine chip versus amoxicillin/metronidazole as adjunctive antimicrobial therapy for generalized aggressive periodontitis: A randomized controlled clinical trial. J Clin Periodontol 2007;34:880-891.
9. Cobb CM. Non-surgical pocket therapy: Mechanical. Ann Periodontol 1996;1:443-490.
10. Jervøe-Storm PM, Semaan E, AlAhdab H, Engel S, Fimmers R, Jepsen S. Clinical outcomes of quadrant root planing versus full-mouth root planing. J Clin Periodontol 2006;33:209-215.
11. Beck JD, Slade G, Offenbacher S. Oral disease, cardiovascular disease and systemic inflammation. Periodontol 2000 2000;23:110-120.
12. Pouliot M, Clish CB, Petasis NA, van Dyke TE, Serhan CN. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: A role of Cyclooxigenasen and lipoxins in periodontal disease. Biochemistry 2000;39:4761-4768.
13. Drisko CH. Non-surgical pocket therapy: Pharmacotherapeutics. Ann Periodontol 1996;1:491-566.
14. Ng VW, Bissada NF. Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis. J Periodontol 1998;69:772-776.
15. Bichara J, Greenwell H, Drisko C, et al. The effect of postsurgical naproxen and a bioabsorbable membrane on osseous healing in intrabony defects. J Periodontol 1999;70:869-877.
16. Holzhausen M, Rossa C Jr., Marcantonio EO Jr., Nassar P, Spolidório DMP, Spolidório LC. Effect of selective cyclooxigenase-2 inhibition on the development of ligature-induced periodontitis in rats. J Periodontol 2002;73:1030-1036.
17. Reddy MS, Geurs NC, Gunsolley JC. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. Ann Periodontol 2003;8:12-37.
18. Aras H, Çaǧlayan F, Güncü GN, Berberoǧlu A, Kilinç K. Effect of systemically administered naproxen sodium on clinical parameters and myeloperoxidase and elastase-like activity levels in gingival crevicular fluid. J Periodontol 2007;78:868-873.
19. American Academy of Periodontology. Glossary of Periodontal Terms, 4th ed. Chicago: American Academy of Periodontology; 2001:39-40.
20. Sheiham A, Netuveli G. Periodontal disease in Europe. Periodontol 2000 2002;29:104-121.
21. Xajigeorgiou C, Sakellari D, Slini T, Baka A, Konstantinidis A. Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis. J Clin Periodontol 2006;33:254-264.
22. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25:229-235.
23. Michelin MA, Figueiredo F, Cunha FQ. Involvement of prostaglandins in the immunosuppression occurring during experimental infection by Paracoccidioides brasillensis. Exp Parasitol 2002;102:170-177.
24. Griffiths GS, Brägger U, Fourmousis I, Sterne JAC. use of an internal standard in subtraction radiography to assess initial periodontal bone changes. Dentomaxillofac Radiol 1996;25:76-81.
25. Hunt RH, Harper S, Callegari P, et al. Complementary studies of the gastrointestinal safety of the cyclooxigenase-2-selective inhibitor etoricoxib. Aliment Pharmacol Ther 2003;17:201-210.
26. Cannon CP, Curtis SP, Bolognese JA, Laine L. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: Cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis. Am Heart J 2006;152:237-245.
27. Airila-Mansson S, Soder B, Soder PO, Kari K, Meurman J. Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood. J Periodontal Res 2006;41:411-417.
28. Jeffcoat MK, Reddy MS, Haigh S, et al. A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodontol 1995;66:329-338.
29. Reddy MS, Palcanis KG, Barnett ML, Haigh S, Charles CH, Jeffcoat MK. Efficacy of meclofenamate sodium (Meclomen) in the treatment of rapidly progressive periodontitis. J Clin Periodontol 1993;20:635-640.
30. Haffajee AD, Dibart S, Kent RL Jr., Socransky SS. Clinical and microbiological changes associated with the use of 4 adjunctive systemically administered agents in the treatment of periodontal infections. J Clin Periodontol 1995;22:618-627.
31. Jeffcoat MK, Page R, Reddy MS, et al. use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodontal Res 1991;26:415-421.
32. Hughes FJ, Syed M, Koshy B, et al. Prognostic factors in the treatment of generalized aggressive periodontitis: I. Clinical features and initial outcome. J Clin Periodontol 2006;33:663-670.
33. Williams RC, Jeffcoat MK, Howell H, et al. Altering the progress of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 1989;60:485-490.
34. Okano T, Mera T, Ohki M, Ishikawa I, Yamada N. Digital subtraction of radiograph in evaluating alveolar bone changes after initial periodontal therapy. Oral Surg Oral Med Oral Pathol 1990;69:258-262.
35. Orstavik D, Farrants G, Wahl T, Kerekes K. Image analysis of endodontic radiographs: Digital subtraction and quantitative densitometry. Endod Dent Traumatol 990;6:6-11.
36. Yoshioka T, Kobayashi C, Suda H, Sasaki T. An observation of the healing process of periapical lesions by digital subtraction radiography. J Endod 2002; 28:589-591.
37. Matteson SR, Deahl ST, Alder ME, Nummikoski PV. Advanced imaging methods. Crit Rev Oral Biol Med 1996;7:346-395.
38. Holzhausen M, Spolidorio DM, Muscará MN, Hebling J, Spolidorio LC. Protective effects of etoricoxib, a selective inhibitor of cyclooxygenase-2, in experimental periodontitis in rats. J Periodontal Res 2005;40: 2008-2011.
39. Azoubel MC, Menezes AM, Bezerra D, Oriá RB, Ribeiro RA, Brito GAC. Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats. Braz J Med Biol Res 2007;40:117-125.